KALV
KalVista Pharmaceuticals, Inc. · Healthcare
CEO Thomas Andrew Crockett sold $162K of KalVista Pharmaceuticals, Inc.
Sold$162,198
$16.22Price
10,000Shares
−8%Stake
What KALV did after the filing
- The stock from Mon, Feb 5 close, $15.85
- −25.3%
- S&P 500, same days
- +5.0%
Measured over 30 trading days, to the Mar 19 close.
Traded Thu, Feb 1. Filed Mon, Feb 5, 12:55 PM ET, during the session. Returns use the Feb 5 close and the Mar 19 close. Not investment advice.